|
|
Vaccine Detail
|
Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A |
| Vaccine Information |
- Vaccine Name: Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007266
- Type: Other
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- NY-ESO-1
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Description: An immunotherapeutic agent targeting the tumor-associated antigen (TAA), cancer/testis antigen NY-ESO-1, with potential antineoplastic activity. (NCIT_C116847).
|
| Host Response |
|
|
| References |
NCIT_C116847: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116847]
|
|
